Class action targets ‘ineffective’ cold medicines

Class action targets ‘ineffective’ cold medicines
(Image: Deposit Photos)
Staff reporters
A class action has been filed claiming a pharmaceutical giant sold and marketed in New Zealand cold medicines that did not work.Australia-based JGA Saddler filed a class action against Johnson & Johnson NZ on Thursday over its phenylephrine-based cold medicines tablets and syrups, claiming they have long been shown to be ineffective.Johnson & Johnson is a United States-based pharmaceutical multinational and is among the 50 largest companies in the world. Its NZ subsidiary last year reported $142 million in local sales.Comment is being s...